top of page

ASCO 2026: "If you look at what happened to KRAS at this conference....we are on that path with beta-catenin." Iterion CEO Rahul Aras describes his company's approach to WNT/beta-catenin and ASCO data

  • Jun 1
  • 1 min read

He describes the biology of WNT/beta-catenin, an undruggable target for decades and why he believes there is now room for optimism. Iterion presented an update of its TBL1 inhibitor in hepatocellular carcinoma today in an oral presentation at ASCO.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page